Doxycycline
Treatment for Cellulitis
Typical Dosage: 100mg orally twice daily
Effectiveness
85%
Safety Score
70%
Clinical Trials
2
Participants
40K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
100mg orally twice daily
Time to Effect
1-2 days
Treatment Duration
7 days
Evidence Quality
HIGHConfidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15
Monitoring:$125
Side Effect Mgmt:$15
Total Annual:$155
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.05
Outcome-Based Costs
Cost per Responder
$182.35
Cost per Remission
$193.75
Prescription Access Economics
Annual Societal Loss per Patient
$1,730
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$150/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$15/year
Potential OTC Price
$5/year
Estimated if OTC available
Early Treatment Benefit
+0.01 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
HIGHMissed Diagnosis Risk
MODERATEDoxycycline Outcomes
for Cellulitis
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+85%
Remission Rate
+80%
Common Side Effects
Photosensitivity
+15%
Nausea
+7%
Vomiting
+7%
Diarrhea
+7%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
2 completed trials for Doxycycline in Cellulitis
Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment
NCT03637400COMPLETEDPHASE2
269 participants
INTERVENTIONAL
Sylmar, United States +2 more
Started: Nov 26, 2018
A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections
NCT01049438COMPLETEDNA
31 participants
INTERVENTIONAL
Started: Aug 1, 2006